The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

Doherty Dearbhla; Patel Anjali; Nolan Margaret; Byrne Mary; Aguila Sonia; OSullivan Jamie M.; Ryan Kevin; OConnell Niamh M.; Lavin Michelle; ODonnell James S.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

【24h】

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

机译：爱尔兰队列的低von Willebrand系列 - 定义低VWF患者程序的最佳管理（30-50 IU / DL）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
作者
Doherty Dearbhla; Patel Anjali; Nolan Margaret; Byrne Mary; Aguila Sonia; OSullivan Jamie M.; Ryan Kevin; OConnell Niamh M.; Lavin Michelle; ODonnell James S.;
展开▼
作者单位

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

Royal Coll Surgeons Ireland Irish Ctr Vasc Biol Dublin 2 Ireland;

Royal Coll Surgeons Ireland Irish Ctr Vasc Biol Dublin 2 Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

St James Hosp Natl Coagulat Ctr Dublin Ireland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL) [J] . Doherty Dearbhla, Patel Anjali, Nolan Margaret, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：爱尔兰队列的低von Willebrand系列 - 定义低VWF患者程序的最佳管理（30-50 IU / DL）
2. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). [J] . Haberichter SL, Castaman G, Budde U, Blood: The Journal of the American Society of Hematology . 2008,第10期

机译：通过在欧洲研究中通过VWF前肽的测定来识别von Willebrand因子存活率降低的1型von Willebrand病患者：诊断和管理1型VWD（MCMDM-1VWD）的分子和临床标志物。
3. EVALUATION OF THE VON WILLEBRAND FACTOR (VWF) INHIBITOR IN A LARGE COHORT OF EUROPEAN AND IRANIAN PATIENTS PREVIOUSLY DIAGNOSED WITH TYPE 3 VON WILLEBRAND DISEASE (VWD3) ENROLLED INTO THE 3WINTER-IPS PROJECT [J] . Baronciani L., Budde U., Stufano F., Archives of disease in childhood . 2019,第Suppla1期

机译：在欧洲和伊朗患者的大型欧洲和伊朗患者诊断患有3型von Willebrand疾病（第VD3）中的欧洲和伊朗患者中的von Willebrand因子（vwf）抑制剂评估纳入3winter-ips项目
4. Estimation of the platelet glycoprotein (GP) Ib - von Willebrand factor (vWf) bond lifetime under hydrodynamic flow [C] . Anand Kumar, R., Jing-fei Dong, . 2002

机译：流体动力流动下血小板糖蛋白（GP）Ib-von Willebrand因子（vWf）键寿命的估算
5. Studies of platelet GPIb-alpha and von Willebrand factor bond formation under flow [D] . Coburn, Leslie Ann 2010

机译：流动条件下血小板GPIb-α和von Willebrand因子键形成的研究
6. Hemostasis Thrombosis and Vascular Biology: Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) [O] . Sandra L. Haberichter, Giancarlo Castaman, Ulrich Budde, -1

机译：止血血栓形成和血管生物学：通过一项欧洲研究中的VWF前肽测定确定von Willebrand因子存活率降低的1型von Willebrand病患者：1型VWD（MCMDM-1VWD）的诊断和治疗分子和临床标记）
7. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) [O] . Haberichter, Sandra L., Castaman, Giancarlo, Budde, Ulrich, 2008

机译：通过欧洲研究中的VWF前肽测定来鉴定von Willebrand因子存活率降低的1型von Willebrand病患者：1型VWD（MCMDM-1VWD）的诊断和治疗的分子和临床标记

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

著录项

相似文献

相关主题

期刊订阅